Holmes MV

No ORCID on file · 2 papers in corpus

meta-analysis 2023

Lowering of Circulating Sclerostin May Increase Risk of Atherosclerosis and Its Risk Factors: Evidence From a Genome-Wide Association Meta-Analysis Followed by Mendelian Randomization

Arthritis & rheumatology (Hoboken, N.J.) ·doi:10.1002/art.42538

OBJECTIVE: In this study, we aimed to establish the causal effects of lowering sclerostin, target of the antiosteoporosis drug romosozumab, on atherosclerosis and its risk factors. METHODS: A genome-wide association study meta-analysis was…

other 2022

Correction: Obesity and risk of female reproductive conditions: A Mendelian randomisation study

PLoS medicine ·doi:10.1371/journal.pmed.1004095

[This corrects the article DOI: 10.1371/journal.pmed.1003679.].